Shimadzu Medical Systems officially moved into the global mammography market at the RSNA show when it signed a nonexclusive distribution and marketing agreement with Planmed. According to terms of the deal, Wood Dale, IL-based Planmed’s Sophie and
Shimadzu Medical Systems officially moved into the global mammography market at the RSNA show when it signed a nonexclusive distribution and marketing agreement with Planmed. According to terms of the deal, Wood Dale, IL-based Planmeds Sophie and Sophie Classic product line will be sold worldwide under Shimadzus own name. The agreement expands a partnership established in 1995 between Planmed and Shimadzu Corporation, which allows Shimadzu to market Planmeds mammography products in Japan under the trade name Sepio. The new agreement extends Shimadzus distribution of Planmed mammography products to North and South America, Europe, and Australia.
The deal allows Shimadzu to fill out its product portfolio and target larger strategic accounts such as group purchasing and veterans organizations and hospital networks, according to Don Karle, director of sales and marketing for North America. The Torrance, CA-based firm plans to sell between 30 and 50 mammography units in 2000, Karle said.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.
Chest CT for Post-COVID-19 Abnormalities: Nine Takeaways from a Multi-Society Consensus Statement
July 22nd 2025Developed by 21 thoracic radiologists, the new international consensus statement addresses appropriate indications, scan acquisition and keys to reporting for the use of chest CT imaging in evaluating for residual lung abnormalities from COVID-19.